---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-333913"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2021-11-18T23:59:59+00:00"
generated_at: "2026-06-28T06:51:43.958923+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad amends credit agreement to add LIBOR fallback, expand EBITDA definition, increase debt/asset sale baskets

## Summary
- Adds LIBOR replacement language to credit agreement; updates benchmark provisions.
- Expands EBITDA to include non-recurring cash expenses (transaction costs, milestone payments, restructuring).
- Provides unlimited cash and cash equivalent basket measured against leverage ratio, net of cash up to $200M globally.
- Increases baskets for indebtedness, asset sales, cross-defaults, and judgment liens.

## SEC filing metadata
- accession: 0001193125-21-333913
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2021-11-18T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000119312521333913/0001193125-21-333913-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000119312521333913/d437115d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-333913
- JSON: https://secwatch.observer/filing/0001193125-21-333913.json
- Plain text: https://secwatch.observer/filing/0001193125-21-333913.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.